An Immune Checkpoint-Related Gene Signature for Predicting Survival of Pediatric Acute Myeloid Leukemia

Table 1

Clinical data from TARGET and GEO datasets of AML patients.

Variables	Subgroups	TARGET (n = 156)	GSE37642 (n = 422)
Age
	<14 years	103	—
	≥14 years	53	—
Gender
	Male	91	—
	Female	65	—
Vital status
	Alive	94	109
	Dead	62	308
	Unknown	0	5
WBC at diagnosis (10^6/L)
	≥50	77	—
	<50	79	—
Bone marrow leukemic blast percentage
	≥90	32	—
	<90	120	—
	Unknown	4	—
CNS disease
	No	146	—
	Yes	10	—